New developments in urinary home self-care for patients in Belgium

15

May 2017

Home self-drilling is the urinary sampling that patient does himself at home or that is done by someone who has been trained for this purpose and who is able to apply this technique.

The purpose of self-sounding is to ensure a regular emptying of the bladder by introducing a probe through the urethra. Patients who undergo home self- drilling are often faced with additional costs due to the purchase of additional probes or the high cost of the probes used. In order to remedy these situations and better meet the real needs of patients, new regulations have been developed; it will enter into force on 1 November 2017.

Currently maximum 5 probes per day are reimbursed if the patient has any of the following conditions:

  • Retention of bladder with significant post-void residual urine (equal to or greater than 100 ml) due to acquired or congenital spinal cord injury;
  • Retention of bladder with significant post-void residual urine (equal to or greater than 100 ml) due to peripheral neuropathy;
  • Paraplegia or paraparesis, tetraplegia or tetraparesis, when the progression of incontinence is prevented by combination of parasympathicolytic drug (s) and self-probe;
  • Bladder retention in the absence of isolated neurological injury: surrogate bladder; enlargement of bladder.

The new regulations allow for the following improvements:

  • Increase the maximum number of probes reimbursed daily: from 4 to 5 probes per day to from 4 to 8 probes per day for two specific conditions;
  • Expansion of the target group;
  • Development of a list of reimbursable probes, with a price control;
  • No amount is charged to patients for the purchase of probes, except for an additional charge of maximum 1 EUR per probe for so-called "advanced" probes (probes with integrated lubricant and other additional functions, if the decision to use these probes has been made on the basis of patient-doctor consultation).

See original document here

The latest related news

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more